Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company makes key appointment following medical cannabis partnership

Debbie Ormsby will lead Canndeo to fast-track medicinal cannabis products into Australia.
The Hydroponics Company makes key appointment following medical cannabis partnership
THC shares have increased five-fold to over $1 since listing in May

The Hydroponics Company Ltd (ASX:THC) has appointed the experienced Debbie Ormsby as chief commercial officer. 

Ormsby brings significant pharmaceutical and biotech expertise with extensive experience in end to end product commercialisation within the pharmaceutical markets.

The appointment follows the company's wholly-owned subsidiary, Canndeo Limited, locking in off-shore supply of medicinal cannabis by entering into a partnership with BOL Pharma.

READ NOW: The Hydroponics Company in company making partnership with Israel's BOL Pharma

BOL Pharma is one of Israel’s leading medicinal cannabis producers.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full THC profile View Profile

Hydroponics Company Ltd Timeline

Related Articles

scientist in lab
September 07 2018
Normally, patients have to wait until regulators have approved a drug before they get access to it, but up to 500 lupus sufferers will receive Lupuzor as part of a Managed Access Programme
cancer cells in blood
July 17 2018
It’s been a tricky year for Redx, but it has come through it with a promising pipeline, cash in the bank and AstraZeneca’s former UK boss as its new chief executive
tumour cells
July 25 2018
Sign-off by the US Food & Drug Administration is considered the "global standard for approval", the company said

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use